Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.930
-0.060 (-1.50%)
Jan 14, 2025, 4:00 PM EST - Market closed
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $302.08 million as of January 15, 2025. Its market cap has increased by 228.51% in one year.
Market Cap
302.08M
Enterprise Value
237.70M
1-Year Change
228.51%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $302.08M, an increase of 255.44%. That is a compound annual growth rate of 24.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.26B |
| UnitedHealth Group | 479.18B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 342.03B |
| AbbVie | 309.55B |
| Merck & Co. | 251.07B |
| AstraZeneca | 207.72B |
| Thermo Fisher Scientific | 207.43B |